FR2270862A1 - Hypolipaemic agent/vitamin E compns - for treatment of hyperlipaemia and hyperlipoproteinaemia which are resistant to hyperlipaemic agents alone - Google Patents

Hypolipaemic agent/vitamin E compns - for treatment of hyperlipaemia and hyperlipoproteinaemia which are resistant to hyperlipaemic agents alone

Info

Publication number
FR2270862A1
FR2270862A1 FR7416994A FR7416994A FR2270862A1 FR 2270862 A1 FR2270862 A1 FR 2270862A1 FR 7416994 A FR7416994 A FR 7416994A FR 7416994 A FR7416994 A FR 7416994A FR 2270862 A1 FR2270862 A1 FR 2270862A1
Authority
FR
France
Prior art keywords
hypolipaemic
hyperlipoproteinaemia
treatment
hyperlipaemic
compns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7416994A
Other languages
English (en)
French (fr)
Other versions
FR2270862B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR7416994A priority Critical patent/FR2270862A1/fr
Publication of FR2270862A1 publication Critical patent/FR2270862A1/fr
Application granted granted Critical
Publication of FR2270862B1 publication Critical patent/FR2270862B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7416994A 1974-05-16 1974-05-16 Hypolipaemic agent/vitamin E compns - for treatment of hyperlipaemia and hyperlipoproteinaemia which are resistant to hyperlipaemic agents alone Granted FR2270862A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7416994A FR2270862A1 (en) 1974-05-16 1974-05-16 Hypolipaemic agent/vitamin E compns - for treatment of hyperlipaemia and hyperlipoproteinaemia which are resistant to hyperlipaemic agents alone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7416994A FR2270862A1 (en) 1974-05-16 1974-05-16 Hypolipaemic agent/vitamin E compns - for treatment of hyperlipaemia and hyperlipoproteinaemia which are resistant to hyperlipaemic agents alone

Publications (2)

Publication Number Publication Date
FR2270862A1 true FR2270862A1 (en) 1975-12-12
FR2270862B1 FR2270862B1 (enExample) 1978-02-03

Family

ID=9138933

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7416994A Granted FR2270862A1 (en) 1974-05-16 1974-05-16 Hypolipaemic agent/vitamin E compns - for treatment of hyperlipaemia and hyperlipoproteinaemia which are resistant to hyperlipaemic agents alone

Country Status (1)

Country Link
FR (1) FR2270862A1 (enExample)

Also Published As

Publication number Publication date
FR2270862B1 (enExample) 1978-02-03

Similar Documents

Publication Publication Date Title
FR2406641A1 (fr) 2,6-diaminonebularines et leur application therapeutique
JPS5412372A (en) Thiazolidine derivative and its preparation
GB1537130A (en) 6,9,21-trihalo-steroids of the pregnane series
JPS5551020A (en) Remedy for rheumatism
JPS5277073A (en) 1-carbamoyl-5-fluorouracil deruvative and anticancer drug containing s ame as effective component
JPS5424895A (en) Pyranochromone derivatives and remedies for allergic disorder
JPS5430183A (en) 3,4-dihydrocarbostyril derivative
SE8001981L (sv) Kompositioner for behandling av glaukom
ES443115A1 (es) Procedimiento para la preparacion de un nuevo diedtr de 19- nor-testosterona-17beta-hidroxidelta4-estren-3-ona.
ES8201524A1 (es) Procedimiento para la obtencion de esteres de trifluormetil-bencilo de efecto pesticida
IT1063334B (it) Trattamento di 1.5 dimetiltetralina per eliminare da essa residui a carattere acido
JPS5417109A (en) Production of aqueous solution for administering into vein
JPS53141239A (en) Derivative of 22trichlormethyll44 nitroobenzolsulfenic acid and exterminating agent for fungus and bacterium * containing said derivative
JPS5218613A (en) Noise prevention device of track
JPS5551018A (en) Carcinostatic agent
ES436058A1 (es) Procedimiento para preparar esteres de acidos pirimidin (2) il-tionofosforicos.
JPS5266626A (en) Non-medical fungicide and anti-phytophagineae agent, and their prepara tion
JPS5422365A (en) Isoxazole derivative, and antiseptic and sntifugal agnets for wood meterials comprising the derivativs as active constituent
JPS5412385A (en) Carbostyril derivative
JPS5430182A (en) Preparation of 3,4-dihydroxycarbostyril derivative
JPS525798A (en) Preparation of pyridopyridazine derivatives
ATE45957T1 (de) 13alpha-alkyl-17beta-(3-acyloxy-propyl)-gonane.
FR2102303A1 (en) Gamma or omega-amino-alpha-diphenylalkano-amides - as protective agents for seeds and plants against animals esp mice and birds
CA1034491A (en) Inhibiting discoloration of aqueous compositions containing hexamethylenetetramine 1,3-dichloropropene salts
JPS5430181A (en) 3,4-dihydrocarbostyril derivative

Legal Events

Date Code Title Description
ST Notification of lapse